Werkgroep Cardiologische centra Nederland

GENETIC-AF (Completed)

A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients with Heart Failure
Medicine
bucindolol
Population
Heart failure
Phase
IIb-IIIa
Starting year
2016
More information
ClinicalTrials.gov

Director of Study

drs. H.G.R. Dorman (Cardioloog)
Roosendaal, Bravis ziekenhuis